title: The role of residues in binding loop A in desflurane and propofol modulation of recombinant 5-HT3A receptor.
abstract: 5-Hydroxytryptamine type 3 (5-HT(3)) receptor is modulated by general anesthetics and regarded as a possible site of anesthetic adverse action. Although two amino acids located in transmembrane (TM) 2 and TM3 of LGICs were reported as critical for allosteric modulation by anesthetics and alcohols, other residues could regulate anesthetic modulation. Earlier studies identified the role of glutamate 129 and phenylalanine 130 in the non-TM extracellular region in the agonist binding and coupling in the 5-HT(3A) receptor. We investigated whether these non-TM amino acids are involved in desflurane and propofol modulation of the 5-HT(3A) receptor in mutant 5-HT(3A) receptors (mutants) expressed in Xenopus laevis oocytes. E129D and F130Y mutants were functionally expressed but E129Y and F130S mutants were not gated by serotonin. The wild type and F130Y mutants demonstrated positive modulation by desflurane at 6 and 12vol.%. In contrast, E129D mutants were inhibited by desflurane in a concentration dependent manner. Propofol (1-100 microM) demonstrated depression of the currents in all receptors examined. These findings suggest the role of non-TM residues in the extracellular domain in the anesthetic modulation of the 5-HT(3A) receptor.
authors.affiliation: Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea.
authors.forename: Bon Nyeo
authors.initials: BN
authors.lastname: Koo
authors.forename: Mi Kyeong
authors.initials: MK
authors.lastname: Kim
authors.forename: Jay
authors.initials: J
authors.lastname: Yang
authors.forename: Kyeong Tae
authors.initials: KT
authors.lastname: Min
mesh_terms: D000595:Amino Acid Sequence; D018685:Anesthetics, Inhalation / Q000008:administration & dosage / Q000494:pharmacology*; D018686:Anesthetics, Intravenous / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001665:Binding Sites / Q000235:genetics; D000077335:Desflurane; D004305:Dose-Response Relationship, Drug; D007530:Isoflurane / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D051379:Mice; D018408:Patch-Clamp Techniques; D017354:Point Mutation; D015742:Propofol / Q000008:administration & dosage / Q000494:pharmacology*; D044406:Receptors, Serotonin, 5-HT3 / Q000235:genetics / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D014982:Xenopus laevis
chemical_list: D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D044406:Receptors, Serotonin, 5-HT3; D011994:Recombinant Proteins; D058831:Serotonin 5-HT3 Receptor Antagonists; D012702:Serotonin Antagonists; D012701:Serotonin; D000077335:Desflurane; D007530:Isoflurane; D015742:Propofol